🇺🇸 Rapid-acting insulin analogs in United States

Rapid-acting insulin analogs (Rapid-acting insulin analogs) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Rapid-acting insulin analogs in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rapid-acting insulin analogs approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rapid-acting insulin analogs in United States?

Emory University is the originator. The local marketing authorisation holder may differ — check the official source linked above.